EVH
Evolent Health Inc - Ordinary Shares - Class A

1,595
Mkt Cap
$783.78M
Volume
3.19M
52W High
$25.22
52W Low
$6.53
PE Ratio
-4.15
EVH Fundamentals
Price
$6.67
Prev Close
$6.60
Open
$6.67
50D MA
$8.51
Beta
0.86
Avg. Volume
2.91M
EPS (Annual)
-$0.8149
P/B
0.86
Rev/Employee
$567,720.22
Loading...
Loading...
News
all
press releases
Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025
Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025 Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025 PR Newswire WASHINGTON...
PR Newswire·23d ago
News Placeholder
More News
News Placeholder
CVS vs. EVH: Which Value-Based Care Stock Deserves Investor Attention?
CVS shows revenue growth and raised guidance, while EVH faces revenue declines but pursues oncology deals and efficiency gains.
Zacks·2mo ago
News Placeholder
Evolent Health (EVH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Evolent Health (EVH) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks·3mo ago
News Placeholder
Evolent Health (EVH) Reports Q2 Loss, Misses Revenue Estimates
Evolent Health (EVH) delivered earnings and revenue surprises of -211.11% and -2.86%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
iRhythm Technologies (IRTC) Reports Q2 Loss, Tops Revenue Estimates
iRhythm Technologies (IRTC) delivered earnings and revenue surprises of +39.62% and +7.47%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Earnings Preview: Evolent Health (EVH) Q2 Earnings Expected to Decline
Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·3mo ago
News Placeholder
Evolent Health (EVH) Stock Jumps 6.9%: Will It Continue to Soar?
Zacks·4mo ago
News Placeholder
UBS Views Evolent Health’s Q2 Outlook And Financing Moves As ‘Incrementally Positive’
The company reaffirmed its full-year adjusted core profit guidance and noted that oncology cost trends remained below forecast through the first two-thirds of the quarter.
Stocktwits·4mo ago
News Placeholder
Evolent Health (EVH) Q1 Earnings Lag Estimates
chainwire·6mo ago
News Placeholder
Evolent Announces Fourth Quarter and Full Year 2024 Results
Evolent Announces Fourth Quarter and Full Year 2024 Results Evolent Announces Fourth Quarter and Full Year 2024 Results PR Newswire WASHINGTON, Feb. 20, 2025 Revenue of $646.5 million for the three...
PR Newswire·8mo ago

Latest EVH News

View

Advertisement|Remove ads.

Advertisement|Remove ads.